Sales and Marketing

The final 2020 monthly edition of Pharmafocus is available to read for free online now! After a long and theatrical …

Genentech has secured FDA approval for Xofluza (baloxavir marboxil) for the post-exposure prevention of influenza in patients at least 12 …

Sanofi’s MenQuadfi combination vaccine has secured approval from the European Commission for the prevention of invasive meningococcal disease caused by …

Hot on the heels of Moderna and Pfizer/BioNTech who both have released very promising data for their mRNA COVID-19 vaccine …

Certain Americans could receive a coronavirus vaccine as early as next month, according to Dr Moncef Slaoui, Chief Scientific Adviser …

The FDA has granted Emergency Use Authorization for Regeneron’s coronavirus antibody treatment which was used to treat President Donald Trump …

A New York judge has ordered Johnson & Johnson to pay $120 million to a woman and her husband after …

Pfizer and BioNTech are reportedly gearing up to submit a formal application for Emergency Use Authorisation to the FDA later …

The European Commission (EC) has just approved its first recombinant influenza vaccine for the European Union, awarding marketing authorisation to …

Rob Barker has been named as the new Chief Executive Officer (CEO) at health communications and market access group OPEN …

Eli Lilly’s Emgality (galcanezumab) is set to become an approved option for the prevention of episodic and chronic migraine on …

US firm Moderna has swooped in with Phase 3 interim data for its own messenger RNA (mRNA) vaccine candidate, mRNA-1273, …

The advent of an effective vaccine could mean a return to normalcy by next winter, argues Professor Uğur Şahin, Professor …

Johnson & Johnson has kicked off a second global Phase 3 trial to assess the safety and efficacy of its …

The British Labour Party has called for the implementation of new legal measures to combat anti-vaccination campaigns on the internet …